Skip to main content
. 2017 Jul 5;178(6):896–905. doi: 10.1111/bjh.14787

Figure 6.

Figure 6

OS by predefined subgroups. aPatients were considered del(17p) positive if any cell was positive; *Interaction P‐value corresponds to del(17p) (yes) versus del(17p) (no); Interaction P‐value corresponds to t(4:14) (yes) versus t(4:14) (no). CI, confidence interval; ELd, elotuzumab + lenalidomide/dexamethasone; HR, hazard ratio; IMiD, immunomodulatory drug; ISS, International Staging System; Ld, lenalidomide/dexamethasone; OS, overall survival.